George Perry (neuroscientist)

Last updated
George Perry
George-Perry.jpg
Born (1953-04-12) April 12, 1953 (age 71)
Citizenship United States
Alma mater Allan Hancock College, UC Santa Barbara, Hopkins Marine Station of Stanford University and Scripps Institution of Oceanography of UC San Diego
Known forWork on neuronal oxidation of nucleic acids in Alzheimer's disease
Awards Denham Harman Research Award [American Aging Association], Alzheimer Award and Medal (twice) Journal of Alzheimer's Disease, ISI highly cited researcher Fellow, Corresponding Member of Sciences Academy of Lisbon, Spanish Royal Academy of Sciences and Mexican Academy of Sciences, Fellow of Linnean Society of London, Microscopy Society of America, Royal Society of Chemistry, Royal Society of Medicine, Society of Biology, Royal College of Pathologists & AAAS
Scientific career
Fields Neurology
Institutions Baylor College of Medicine, Case Western Reserve University, U Alaska U Texas San Antonio
Doctoral advisor David Epel
Other academic advisors Bill Brinkley,
Notable students Paula Moreira, Mark Smith

George Perry (born April 12, 1953) is a professor of biology and chemistry at the University of Texas at San Antonio and the former dean of the College of Sciences. Perry is recognized in the field of Alzheimer's disease research, particularly for his work on oxidative stress.

Contents

Education

Perry received his Bachelor of Arts degree in zoology from University of California, Santa Barbara. After graduation, he studied at Scripps Institution of Oceanography, Hopkins Marine Station of Stanford University, and the Marine Biological Laboratory at Woods Hole; he obtained his Ph.D. from the University of California at San Diego in Marine Biology under David Epel in 1979. He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of William R. Brinkley, Joseph Bryan and Anthony R. Means at Baylor College of Medicine where he laid the foundation for his observations of cytoskeletal abnormalities.

Professional appointments

In 1982, Perry joined the faculty of Case Western Reserve University, where he holds an adjunct appointment. He is dean of the College of Sciences and professor of biology at the University of Texas at San Antonio. He is distinguished as one of the top Alzheimer's disease researchers [1] [2] with over 1000 publications, one of the top 100 most-cited scientists [3] in Neuroscience & Behavior and one of the top 25 scientists in free radical research. [4] Perry is highly cited (over 82,500 times;H=137;ISI/over 124,000 times;H=175;Google Scholar) and is recognized as an ISI highly cited researcher. [5]

Perry is the current and founding editor-in-chief for the Journal of Alzheimer's Disease , an international multidisciplinary journal that specialises in Alzheimer's disease. [6] He is also a member of the Alzheimer's Foundation of America Medical, Scientific, and Memory Screening Advisory Board. [7]

Perry is fellow of the American Association for the Advancement of Sciences, Sigma Xi , Microscopy Society of America, International Engineering and Technology Institute (IETI), Texas Academy of Sciences, past president and past-interim executive director of the Southwestern and Rocky Mountain Division of American Association for the Advancement of Sciences, past chair of the board of the National Organization of Portuguese Americans and past president of the American Association of Neuropathologists.

Research focus

Perry's research is primarily focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. [8] He has played a key role in elucidating oxidative damage as the initial cytopathological abnormality in Alzheimer disease. He is currently working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. His current studies focus on two issues: (i) the metabolic basis for the mitochondrial damage restricted to vulnerable neurons; and (ii) the consequences of RNA oxidation on protein synthesis rate and fidelity.

Related Research Articles

<span class="mw-page-title-main">Marine Biological Laboratory</span> Research institution in Woods Hole, Massachusetts, United States

The Marine Biological Laboratory (MBL) is an international center for research and education in biological and environmental science. Founded in Woods Hole, Massachusetts, in 1888, the MBL is a private, nonprofit institution that was independent for most of its history, but became officially affiliated with the University of Chicago on July 1, 2013. It also collaborates with numerous other institutions.

The University of Texas Southwestern Medical Center is a public academic health science center in Dallas, Texas. With approximately 23,000 employees, more than 3,000 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and the State of Texas.

<span class="mw-page-title-main">University of Texas Health Science Center at San Antonio</span> Academic hospital in San Antonio,Texas, US

UT Health San Antonio is a public academic health science center in San Antonio, Texas. It is part of the University of Texas System.

<span class="mw-page-title-main">University of Texas at San Antonio College of Sciences</span> Science and research education college

The College of Sciences at the University of Texas at San Antonio in San Antonio, Texas is a science and research education college. The college hosts more than 6000 students enrolled in fifteen undergraduate programs and nineteen graduate programs. The eight departments employ over 300 tenure and non-tenure track faculty members. Students collaborate through programs with local external research institutions including UT Health Science Center, Southwest Research Institute and the Southwest Foundation for Biomedical Research.

Mark Anthony Smith was a professor of pathology at Case Western Reserve University in Cleveland, Ohio, where he also served as the Director of Basic Science Research at the University Memory and Aging Center. At the time of his death, he had been serving as Executive Director of the American Aging Association.

<span class="mw-page-title-main">Gregory Petsko</span> American biochemist and academic

Gregory A. Petsko is an American biochemist and member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society. He is currently Professor of Neurology at the Ann Romney Center for Neurologic Diseases at Harvard Medical School and Brigham and Women's Hospital. He formerly had an endowed professorship in Neurology and Neuroscience at Weill Cornell Medical College and is still an adjunct professor of Biomedical Engineering at Cornell University, and is also the Gyula and Katica Tauber Professor, Emeritus, in biochemistry and chemistry at Brandeis University. On October 24, 2023, in a ceremony in the East Room of the White House, President Joe Biden presented Gregory Petsko and eight others with the National Medal of Science, the highest honor the United States can bestow on a scientist and engineer.

<span class="mw-page-title-main">Robert Gerlai</span> Canadian behaviour geneticist

Robert T. Gerlai is a Canadian behaviour geneticist and behavioural neuroscientist.

<span class="mw-page-title-main">Jan-Åke Gustafsson</span> Swedish biochemist

Jan-Åke Gustafsson is a Swedish scientist and professor in Biology, Biochemistry and Medical Nutrition. When he decided to move to Houston, Texas, USA, in 2008, the State of Texas decided to give a major US $5.5 million research grant to the University of Houston, enabling the establishment of the Center of Nuclear Receptors and Cell Signaling under the leadership of Jan-Åke Gustafsson. The grant was announced at a February 5, 2009, press conference by Rick Perry, Governor of Texas and running for the Republican nomination for President of the United States in the 2012 presidential election.

John Quinn Trojanowski was an American academic research neuroscientist specializing in neurodegeneration. He and his partner, Virginia Man-Yee Lee, MBA, Ph.D., are noted for identifying the roles of three proteins in neurodegenerative diseases: tau in Alzheimer's disease, alpha-synuclein in Parkinson's disease, and TDP-43 in Amyotrophic Lateral Sclerosis (ALS) and frontotemporal degeneration.

The Barshop Institute for Longevity and Aging Studies is a basic and clinical research institute located on the Texas Research Park Campus of the University of Texas Health Science Center at San Antonio (UTHSCSA). It is a leading institute in the United States in geriatrics research. The Barshop Institute ranks #1 in National Institute on Aging funding among Texas institutions, and is highly ranked in the country in National Institute of Health funding. The scientific director of the institute has been Nicolas Musi, M.D. since September 2013. In 2009, one of the research projects of the institute was announced by Science magazine as one of the top scientific discoveries of the year.

Gerald Muench is a senior faculty in the discipline of Pharmacology and has been working as Founder Chair, Pharmacology Department, UWS School of Medicine, University of Western Sydney.

John P. Blass, physician, biochemist and neurochemist, was born on February 21, 1937, in Vienna, Austria, and deceased March 12, 2023, in New York City. Both his parents were physicians; his father, Gustaf Blass, was a prominent Viennese radiologist and his mother, Jolan Wirth Blass, a student of Sigmund Freud, was a psychoanalyst originally from Budapest. The family then moved to Stamford, Connecticut. Both parents practiced psychiatry, Gustaf in a private sanitarium in Stamford and Jolan as a child psychiatrist in New York City and Connecticut. He is survived by his wife, son and two granddaughters.

<span class="mw-page-title-main">Suh Yoo-hun</span> South Korean neuroscientist (born 1948)

Suh Yoo-hun is a South Korean neuroscientist. His researches focus on neurodegeneration, especially on the discovery of genes and therapies for Alzheimer's disease and Parkinson's disease.

<span class="mw-page-title-main">Yves Agid</span> French physician

Yves Agid is a neurologist, neuropsychiatrist, cell biologist, neurochemist, academician, university professor, hospital doctor, researcher in biology and scientist specializing in neurosciences.

<span class="mw-page-title-main">Rajiv Ratan</span> American physician

Rajiv Ratan is an Indian American academic, professor, administrator and scientist based in New York. He is the Burke Professor of Neurology and Neuroscience at Weill Cornell Medicine. Since 2003, he has served as the executive director of Burke Neurological Institute and as a member of the Council of Affiliated Deans of Weill Cornell Medicine.

Kochupurackal P. Mohanakumar is an Indian chemical biologist, neuroscientist and the director of Inter University Centre for Biomedical Research and Super Specialty Hospital, Kottayam. He is a former chief scientist at the Indian Institute of Chemical Biology and is known for his studies on Parkinson's disease and Huntington's disease. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2000.

<span class="mw-page-title-main">Mahmoud Maina</span> Nigerian Neuroscientist

Mahmoud Bukar Maina is a British-Nigerian neuroscientist, educator, and researcher, based at the University of Sussex in the United Kingdom. His research is focused on the cellular and molecular pathogenesis in Alzheimer's disease. He performs outreach work to inspire young people in Africa to pursue science and to increase public understanding of science. He is the Honorary Special Adviser on Science, Research, and Innovation to Governor Mai Mala Buni of Yobe State, Nigeria.

Joseph Thomas Coyle Jr. is an American psychiatrist and neuroscientist. He is the Eben S. Draper Professor of Psychiatry and Neuroscience at Harvard Medical School.

Ana Cristina Rego is a Portuguese neurologist. She is a professor at the University of Coimbra in Portugal and is head of the research group on Mitochondria and Neurodegenerative disorders, researching on topics such as Alzheimer's disease, Huntingdon's disease, and Parkinson's disease. She is presently president of the Portuguese Society of Neuroscience.

James Affram Adjaye is a Ghanaian British Stem cell scientist. He is the Director of the Institute for Stem Cell Research and Regenerative Medicine at the Heinrich Heine University's faculty of medicine. He also led the Molecular Embryology and Aging Group of the Max Planck Institute for Molecular Genetics situated in Berlin, Germany.

References

  1. Alzheimer's Disease
  2. Sorensen, AA (2009). "Alzheimer's disease research: scientific productivity and impact of the top 100 investigators in the field". J Alzheimers Dis. 16 (3): 451–65. doi: 10.3233/JAD-2009-1046 . PMID   19221406.
  3. "in-cites - The 100 Most-Cited Scientists in Neuroscience". Archived from the original on 2015-09-24. Retrieved 2009-06-21.
  4. Lab Registry Archived 2008-08-21 at the Wayback Machine
  5. Researcher ID Profile
  6. "Journal of Alzheimer's Disease Board" . Retrieved 2018-03-20.
  7. "Alzheimer's Foundation of America Medical, Scientific, and Memory Screening Advisory Board" . Retrieved 2022-03-04.
  8. "George Perry Academic Research (UTSA faculty website)". UTSA.edu. Archived from the original on 30 November 2012. Retrieved 9 May 2014.